Neural Correlates of Sensory Phenomena in Tourette Syndrome
1 other identifier
observational
50
1 country
1
Brief Summary
The most pervasive sensory manifestation of TS is sensory over-responsivity (SOR). SOR is defined as excessive behavioral response to commonplace environmental stimuli. SOR is an integral but poorly understood facet of the TS phenotype, one intertwined with core elements of the disorder and worse QOL. This proposal seeks to clarify the mechanistic bases of SOR in TS. Adults with with TS will be recruited 1) to complete a standardized clinical symptom assessment battery and 2) to undergo electroencephalogram (EEG), autonomic, and audio-visual monitoring during tactile and auditory stimuli paradigms, as well as at rest.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 11, 2019
CompletedFirst Posted
Study publicly available on registry
April 16, 2019
CompletedStudy Start
First participant enrolled
July 20, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 28, 2027
January 14, 2026
January 1, 2026
5.6 years
April 11, 2019
January 12, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Network oscillations in response to sensory stimuli
Neural activity captured on EEG can be spectrally decomposed into various frequency constituencies. Neural activity in the gamma frequency range, so-called gamma band oscillations (GBOs), are associated with sensory processing and integration and are postulated to underlie sensory phenomena in TS.
Baseline
Heart rate variability
Change beat-to-beat variability in heart rate
Baseline
Electrodermal activity in response to sensory stimuli
Sweat response changes within 1-3 seconds of non-aversive sensory stimulus
Baseline
Secondary Outcomes (12)
Premonitory Urge to Tic Scale (PUTS)
Within 1 week of baseline
Yale Global Tic Severity Scale (YGTSS)
Within 1 week of baseline
Dimensional Obsessive Compulsive Scale (DOCS)
Within 1 week of baseline
Adult ADHD Self-Report Screening Scale
Within 1 week of baseline
Generalized Anxiety Disorder 7 (GAD-7)
Within 1 week of baseline
- +7 more secondary outcomes
Study Arms (2)
Tourette Syndrome
Adults (\>18 years of age) with diagnosis of Tourette syndrome
Healthy Control
Adults who are generally healthy with no known neurologic or psychiatric diagnoses
Interventions
EEG testing procedure, comprised of somatosensory and auditory event-related potential paradigms, as well as resting state EEG
Autonomic function testing procedure, comprised of electrodes to determine heart rate variability and electrodermal activity (EDA)
Eligibility Criteria
The two groups of participants will include: 1. adult with Tourette syndrome or other chronic tic disorder 2. healthy controls
You may qualify if:
- Diagnosis of Tourette syndrome or other chronic tic disorder
- ≥ 18 years of age
- Ability to complete survey instruments
- English fluency (given that all scales are validated in English)
You may not qualify if:
- \- Known diagnosis of autism spectrum disorder, developmental delay, cerebral palsy, other significant neurologic disease, schizophrenia, or psychotic disorders will be excluded, in order to lessen potentially confounding factors.
- (Note: Patients with OCD, ADHD, anxiety, and/or depression will be permitted, given that these diagnoses are widely prevalent in the adult TS population.)
- Use of anti-seizure medications, stimulants, or other psychotropic medications known to alter EEG signal
- Recreational substance use within past 30 days
- ≥ 18 years of age AND age within 5 years of a participant in the TS arm of same biological sex (for purposes of age- and sex-matching)
- Ability to complete survey instruments
- English fluency (given that all scales are validated in English)
- Any neurologic or psychiatric diagnoses
- History of tics
- Use of any psychotropic medications within the past 30 days
- Recreational substance use within past 30 days
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Vanderbilt University Medical Center
Nashville, Tennessee, 37232-5400, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
April 11, 2019
First Posted
April 16, 2019
Study Start
July 20, 2021
Primary Completion (Estimated)
February 28, 2027
Study Completion (Estimated)
February 28, 2027
Last Updated
January 14, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- The above information will be available for sharing within 6 months of publication.
- Access Criteria
- Researchers wishing to access the above information should contact the investigative team and provide: 1) hypothesis-driven scientific question for which the data will be analyzed and 2) proposed methods for responsibly analyzing the data.
De-identified clinical variables, EEG data, and autonomic data metrics may be shared with other researchers.